Luca Maurillo, Adriano Venditti, Alessandra Spagnoli, Gianluca Gaidano, Dario Ferrero, Esther Oliva, Monia Lunghi, Alfonso M. D'Arco, Alessandro Levis, Domenico Pastore, Nicola Di Renzo, Alberto Santagostino, Vincenzo Pavone, Francesco Buccisano and Pellegrino Musto Azacitidine for the treatment of patients with acute myeloid leukemia Cancer 118
Version of Record online: 14 JUL 2011 | DOI: 10.1002/cncr.26354
The efficacy of azacitidine for the treatment of high-risk myelodysplastic syndromes prompted an investigation into its potential role in acute myeloid leukemia (AML); therefore, the authors of this report carried out a multicenter, retrospective analysis of 82 Italian patients with AML who received azacitidine. The current results indicated that azacitidine has promise as an effective therapy for elderly patients with untreated AML who have white blood cell counts <10 × 109/L.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field